Treatment of infections caused by multidrug-resistant gram-negative bacteria: Report of the British society for antimicrobial chemotherapy/healthcare infection society …

PM Hawkey, RE Warren, DM Livermore… - Journal of …, 2018 - academic.oup.com
Abstract The Working Party makes more than 100 tabulated recommendations in
antimicrobial prescribing for the treatment of infections caused by multidrug-resistant (MDR) …

β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of …

PNA Harris, PA Tambyah, DL Paterson - The Lancet Infectious …, 2015 - thelancet.com
The spread of extended-spectrum β-lactamase (ESBL) genes in Enterobacteriaceae such as
Escherichia coli or Klebsiella spp is a major challenge to modern medical practice …

Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective

A Brolund - Infection ecology & epidemiology, 2014 - Taylor & Francis
Extended spectrum β-lactamases (ESBL) are increasing rapidly worldwide. E. coli producing
CTX-M type ESBLs are the most common clinically encountered. The majority of E. coli …

[HTML][HTML] Bloodstream infections in cancer patients. Risk factors associated with mortality

B Islas-Muñoz, P Volkow-Fernández… - International Journal of …, 2018 - Elsevier
Objective The aim of this study was to evaluate the clinical characteristics and risk factors
associated with mortality in cancer patients with bloodstream infections (BSI), analyzing …

Infecciones causadas por bacterias gramnegativas multirresistentes: enterobacterias, Pseudomonas aeruginosa, Acinetobacter baumannii y otros bacilos …

MC Fariñas, L Martínez-Martínez - Enfermedades infecciosas y …, 2013 - Elsevier
Las bacterias gramnegativas multirresistentes son un grave problema de salud en todo el
mundo. Ello se relaciona con la gravedad de las infecciones que pueden causar, las …

[HTML][HTML] Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study

B Denis, M Lafaurie, JL Donay, JP Fontaine… - International Journal of …, 2015 - Elsevier
Background The impact of extended-spectrum beta-lactamase (ESBL)-producing
Escherichia coli (ESBL-EC) bacteraemia on outcome remains controversial. Methods A …

Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients–Review of the literature from a clinical …

LM Biehl, M Schmidt-Hieber, B Liss… - Critical reviews in …, 2016 - Taylor & Francis
Background: The prevalence of extended-spectrum β-lactamase producing
Enterobacteriaceae (ESBL-E) is increasing worldwide. ESBL-E are known to colonize …

Clinical management of infections caused by multidrug-resistant Enterobacteriaceae

M Delgado-Valverde, J Sojo-Dorado… - Therapeutic …, 2013 - journals.sagepub.com
Enterobacteriaceae showing resistance to cephalosporins due to extended-spectrum β-
lactamases (ESBLs) or plasmid-mediated AmpC enzymes, and those producing …

Effects of inappropriate administration of empirical antibiotics on mortality in adults with bacteraemia: systematic review and meta-analysis

YP Hung, CC Lee, WC Ko - Frontiers in medicine, 2022 - frontiersin.org
Introduction Bloodstream infections are associated with high mortality rates and contribute
substantially to healthcare costs, but a consensus on the prognostic benefits of appropriate …

The challenge of antibiotic resistance in haematology patients

O Blennow, P Ljungman - British journal of haematology, 2016 - Wiley Online Library
Bacterial infections were once a major obstacle to the treatment of acute leukaemia.
Improvement in management strategies, including the use of broad‐spectrum antibacterial …